3d
The National Interest on MSNDid A Russian Pantsir-S1 Short-Range Missile Just Shoot Down A Ukrainian JDAM?The Pantsir-S1 is devastating against small, fast, or low-flying threats—of the kind that U.S.-built drones and JDAMs pose.
The US Air Force and Special Operations Command are preparing to field the new low-cost close air support platform developed ...
A U.S. Marine Corps F-35B flew the first test missions with the Meteor missile, starting the integration of the European ...
12d
The Aviationist on MSNU.S. Air Force Completes Final F-16 Sortie at Luke AFBAfter 42 years, the 56th Fighter Wing completed its final U.S. local training sortie with the F-16 and will now focus only on ...
Certainly, it’s OK with me if he’d like to.” A damaged apartment building is seen after a Russian guided aircraft bomb attack in Kostiantynivka, Donetsk region, Ukraine, Monday, Feb. 24, 2025. (AP ...
What is Direct Laser Microfusion? OsseoMatrix developed Direct Laser Microfusion as .a revolutionary 3D printing process for ceramics which leverages powder bed fusion to directly process ceramic ...
Vermont Business Magazine Sen. Bernie Sanders (I-Vermont) last week filed four Joint Resolutions of Disapproval (JRDs) that would block the sale of $8.56 billion in offensive U.S. weaponry to Israel.
Examples include the French Katana, the American Excalibur, and Laser JDAM bombs. Turkey is also developing its own family of laser-guided munitions, supplemented with 155 mm shells and anti-tank ...
The Russians attacked Kharkiv with a guided aerial bomb (GAB) at dawn on 24 February, hitting a civilian enterprise in the Kyivskyi district of the city. Quote from Terekhov: "The attack actually took ...
The remains of the 14 SANDF soldiers who were killed in the DRC arrived at the Swartkop Air Force Base in Pretoria where they were handed over to their families during a military ceremony on 13 ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it will present additional data from the pivotal Phase 3 OASIS and OASISplus studies, as well as ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it will present additional data from the pivotal Phase 3 OASIS and OASISplus studies, as well as three year data from the Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results